comparemela.com

Latest Breaking News On - Yatharth hospital - Page 4 : comparemela.com

S&P BSE Rejig: Honasa Consumer added to BSE FMCG Index, Tata Tech to BSE IT Index

What is metastatic cervical cancer actress Dolly Sohi suffered from?

What is metastatic cervical cancer actress Dolly Sohi suffered from?
hindustantimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hindustantimes.com Daily Mail and Mail on Sunday newspapers.

Mumbai
Maharashtra
India
Hindustan
India-general
New-delhi
Delhi
Kumkum-bhagya
Roli-banthia
Rahul-manchanda
Actor-dolly-sohi

GPT Healthcare share price: GPT Healthcare shares list at 16% premium over IPO price

GPT Healthcare s IPO debuted with a 16.2% premium. It raised Rs 525 crore for prepayment/repayment of borrowings. The company operates four multispecialty hospitals. Revenue grew at 53.87% CAGR. Three-month total income was Rs 97.63 crore, net profit was Rs 9.98 crore.

Kolkata
West-bengal
India
Krishna-institute-of-medical-sciences
Global-health
Mukka-proteins
Krishna-institute
Medical-sciences
Jupiter-lifeline-hospitals
Yatharth-hospital
Link-intime-india

GPT Healthcare debut exceeds expectations. Should you wait for more upside?

The shares of GPT Healthcare debuted with a 15% premium over the issue price on Thursday, which was slightly above expectations. Most analysts priced in a 9-10% premium listing.

India
Shivani-nyati
Krishna-institute-of-medical-sciences
Global-health
Eastern-india
Krishna-institute
Medical-sciences
Jupiter-lifeline-hospitals
Yatharth-hospital

GPT Healthcare to debut tomorrow. Here's what GMP indicates ahead of listing

The shares of GPT Healthcare will debut on the exchanges on Thursday. Ahead of the listing, the company s shares are trading with a premium of Rs 17 in the unlisted market.

India
Global-health
Krishna-institute-of-medical-sciences
Krishna-institute
Medical-sciences
Jupiter-lifeline-hospitals
Yatharth-hospital
Link-intime-india

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.